These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 3526665)
1. Proceedings of an international symposium on monoclonal antibody therapy with orthoclone OKT3 in renal transplantation. Transplant Proc; 1986 Aug; 18(4):923-56. PubMed ID: 3526665 [No Abstract] [Full Text] [Related]
2. [Use of Orthoclone OKT3 in salvage treatment of primary acute renal allograft rejection resistant to steroids and antilymphocyte globulins]. Guérin C; Daoud M; Paysant B; Sabatier JC; Berthoux P; Berthoux F Nephrologie; 1988; 9(6):282-3. PubMed ID: 3070430 [No Abstract] [Full Text] [Related]
3. Use of Orthoclone OKT3 as treatment of acute renal allograft rejection and as first-line therapy in kidney transplantation. Winde G; Dietl KH; Raidt H; Buchholz B; Lison AE; Bünte H Transplant Proc; 1988 Oct; 20(5 Suppl 6):87-9. PubMed ID: 3140453 [No Abstract] [Full Text] [Related]
4. [Treatment of kidney graft rejection with a monoclonal antibody (Orthoclone OKT-3)]. Ladefoged SD; Friedberg M; Glenthøj A Ugeskr Laeger; 1988 Nov; 150(48):2974-6. PubMed ID: 3144080 [No Abstract] [Full Text] [Related]
5. Fine-needle aspiration cytology during treatment with orthoclone monoclonal antibody OKT3 for acute cellular rejection after renal transplantation. Hansen BL; Foged N; Nielsen E; Elbirk A; Rohr N; Svendsen V; Birkeland SA Transplant Proc; 1988 Aug; 20(4):626-8. PubMed ID: 2970142 [No Abstract] [Full Text] [Related]
7. [Neurologic complications induced by the treatment of the acute renal allograft rejection with the monoclonal antibody OKT3]. Fernández O; Romero F; Bravo M; Burgos D; Cabello M; González-Molina M Neurologia; 1993 Oct; 8(8):277-80. PubMed ID: 8240843 [TBL] [Abstract][Full Text] [Related]
8. Muromonab-CD3 (Orthoclone OKT3): the first monoclonal antibody approved for therapeutic use. Emmons C; Hunsicker LG Iowa Med; 1987 Feb; 77(2):78-82. PubMed ID: 3557906 [No Abstract] [Full Text] [Related]
9. Reversing cardiac transplant rejection with Orthoclone OKT3. Dault LA; Nagy CS; Collins JA Am J Nurs; 1989 Jul; 89(7):953-5. PubMed ID: 2500020 [No Abstract] [Full Text] [Related]
10. Therapeutic use of the OKT3 anti-T cell monoclonal antibody: mode of action and side effects. Chatenoud L Transplant Proc; 1988 Oct; 20(5 Suppl 6):79-83. PubMed ID: 3140452 [No Abstract] [Full Text] [Related]
11. The prophylactic use of Orthoclone OKT3 in kidney and heart transplantation. Weimar W; Baumgartner D; Hendriks GF; Hesse CJ; Balk AH; Simoons ML; Bos E Transplant Proc; 1988 Oct; 20(5 Suppl 6):96-100. PubMed ID: 3140455 [No Abstract] [Full Text] [Related]
12. Orthoclone OKT3 and cardiac transplantation: an overview. Mahon PM Crit Care Nurse; 1991 Sep; 11(8):42-7, 50. PubMed ID: 1909947 [No Abstract] [Full Text] [Related]
13. Clinical development of Orthoclone OKT3. Cosimi AB Transplant Proc; 1987 Apr; 19(2 Suppl 1):7-16. PubMed ID: 3105142 [No Abstract] [Full Text] [Related]
14. Monoclonal antibody OKT3 in cardiac and renal transplantation. Norman DJ Bibl Cardiol; 1988; (43):27-32. PubMed ID: 3147656 [No Abstract] [Full Text] [Related]